From October 1, 2023 to December 31, 2023, the company has repurchased 3,762,100 shares, representing 1.03% for ¥5,053.95 million. With this, the company has completed the repurchase of 12,571,400 shares, representing 3.38% for ¥16,178.35 million under the buyback announced on May 11, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,529 JPY | +0.39% | +2.51% | +8.83% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.83% | 3.62B | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2023.